Please login to the form below

Not currently logged in

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech raises €290m for mRNA cancer vaccine platform

That followed a January deal to add a monoclonal antibody platform developed by fellow German biotech MAB Discovery, and a collaboration with the University of Pennsylvania on mRNA vaccines for infectious ... diseases. There has been a busy few months on

Latest news

More from news
Approximately 4 fully matching, plus 171 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and

  • Searching for health Searching for health

    year. The pharma work is organised into therapeutic areas covering cancers, infectious diseases, immunology, cardiovascular and metabolism diseases with each having dedicated research teams managing all aspects - from finding new compounds

  • The world is our laboratory The world is our laboratory

    Our goal is to improve patient outcomes in the most serious unmet medical needs of our time, including neglected diseases. ... Focused specialties. At Janssen, we have focused our research into five important therapeutic areas: Cardiovascular &Metabolic

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • emotive adds to medical team with new Scientific Lead and Associate Medical Writer

    Following a busy year and with a number of new Global and EMEA account wins including two pre-launch products for rare diseases, emotive has strengthened the medical team with the ... in rare diseases such as Gaucher disease and Cushing’s disease

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Australian Flu and the dilemma of naming diseases

    In recent times, the potentially damaging consequences of ‘naming’ infectious diseases have been identified, and in 2015 the World Health Organisation (WHO) introduced its ‘Best Practices for the Naming of New ... Human Infectious Diseases’,


    cardiovascular disease . diabetes. women’s health . nutrition . allergy . infectious diseases . wound care .

  • New insights into making behavioural change work

    The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. ... Lifestyle conditions, or noncommunicable diseases (NCDs),

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...